Clinical Characteristics and Surgical Outcomes of the Fellow Eye in Bilateral Retinal Detachments
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Feb 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the characteristics and outcomes of surgery for retinal detachment in patients who have had the same issue in both eyes. Specifically, it will focus on those who have undergone surgery to repair retinal detachment in both eyes at a hospital in Nancy, France, between January 2016 and December 2023. The goal is to understand how well surgery works in these cases and what common features these patients share.
To be eligible for the trial, patients must be between the ages of 65 and 74 and have had repair surgery for retinal detachment in both eyes, with at least six months of follow-up after their last surgery. However, those who had their surgery at a different hospital, have had previous eye surgeries, or have certain eye conditions related to trauma or genetics will not be included. Participants can expect to share their experiences and medical history, which will help researchers gather valuable information to improve treatment for future patients with similar eye problems.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients that underwent retinal detachment repair surgery for bilateral sequential retinal detachment between January 2016 and December 2023 at the Nancy Regional and University Hospital Center (via pars plana vitrectomy or scleral buckling) and with a minimum of 6 month of post-operative follow-up after the last surgery.
- Exclusion Criteria:
- • Patients that underwent surgery at another facility
- • Patients with a history of previous vitrectomy or
- • Patients with a history of trauma from a penetrating injury or ruptured globe, retinal neovascular condition, hereditary vitreo-retinopathy
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vandoeuvre Les Nancy, Meurthe Et Moselle, France
Patients applied
Trial Officials
Jean-Baptiste Conart, MD, PhD
Principal Investigator
CHRU de Nancy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported